The new technology licence agreement provides Luxell with a world-wide exclusive licence for commercialization of NRC's electroluminescent flat panel display contrast enhancement technology, which is considered background intellectual property (IP) to Luxell's extensive Black Layer(TM) display contrast enhancement IP portfolio.

The combined IP portfolio provides Luxell the continued right to pursue global commercial licensing of its Black Layer(TM) contrast enhancement technologies, which recently have been optimized for application to the emerging Organic Light Emitting Diode (OLED) technologies. This newly signed agreement supercedes a similar agreement previously executed by the parties in 2001, and will be in effect for up to four years.

Merck - Advancing Display, Advancing LifeMerck - Advancing Display, Advancing Life